期刊文献+

基因多态性与缺血性脑卒中氯吡格雷抵抗关系的研究进展 被引量:7

下载PDF
导出
摘要 综述基因多态性与缺血性脑卒中氯吡格雷抵抗的研究进展。氯吡格雷抵抗的病人具有极高的心肌梗死、非致命性卒中、死亡等发生的风险,是接收经皮冠状动脉内支架术(PCI)的病人出现支架内血栓的重要影响因素。因此,预先评估病人接受氯吡格雷后血小板的抑制水平,早期筛选及发现氯吡格雷抵抗病人,有助于医生在临床上及时进行相应处理措施的选择,从而获得更为理想的治疗效果,对病人的生存率及生活质量均具有重要作用。
作者 胡畔 何志义
出处 《中西医结合心脑血管病杂志》 2019年第21期3351-3354,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 国家自然科学基金(No.81070913)
  • 相关文献

参考文献5

二级参考文献115

  • 1Sacco RL, Adams R, Albers G, et al; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37:577 -617.
  • 2Bhatt DL, Fox KA, Hacke W, et al; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med, 2006, 354:1706 - 1717.
  • 3Diener HC, Bogousslavsky J, Brass LM, et al; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004, 364:331 -337.
  • 4ESPRIT Study Group, Halkes PH, van Gijn J,Kappelle LJ, et al. AAspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet, 2006, 367:1665 - 1673.
  • 5Lindgren A, Husted S, Staaf G, et al. Dipyridamole and headache: a pilot study of initial dose titration. J Neurol Sci, 2004, 223:179 - 184.
  • 6Chang YJ, Ryu SJ, Lee TH. Dose titration to reduce dipyridamolerelated headache. Cerebrovasc Dis, 2006, 22:258 -262.
  • 7Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med, 2004, 164: 722 - 732.
  • 8Goldstein LB, Adams R, Alberts MJ, et al; American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 2006, 37:1583 -1633.
  • 9Pandey DK, Gorelick PB. Should statin agents be administered to all patients with ischemic stroke? Arch Neurol, 2005,62:23 -24.
  • 10Amarenco P, Bogousslavsky J, Callahan A 3rd, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006, 355 : 549 - 559.

共引文献177

同被引文献76

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部